Ledger.Open graph →
SEC Form D · filed March 9, 2018

Humacyte, Inc

Offering
$75.0M
Sold
$75.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Adam H. Hennessey · BOSTON, MADirectorPaul A. Boyer · Durham, NCExecKenneth Musen · New York, NYDirectorWilliam W. Mcguire · Nashville, TNExec · DirectorRobert S. Langer · Durham, NCDirectorBenjamin L. Muchoki · DALLAS, TXDirectorKathleen A. Sebelius · Durham, NCDirectorMax N. Wallace · Durham, NCDirectorBrady W. Dougan · Durham, NCDirectorJames D. Rubin · New York, NYDirectorLaura E. Niklason · Durham, NCDirectorScott Sherman · MIAMI, FLDirectorDouglas W. Turner · ALBUQUERQUE, NMDirectorDan Juran · CHICAGO, ILExecThomas A. Gallagher · Nashville, TNExecVincent S. Capone · NEW YORK, NYExec · DirectorSteven Deitch · New York, NYExecKirk A. Stapleton · Nashville, TNDirectorDavid S. Bradford · Nashville, TNDirectorDale A. Sander · Durham, NCDirectorRobert Anderson · Durham, NCDirectorMichael Brooks · New York, NYExecBenjamin Mandell · MIAMI, FLDirectorRobert L. Moyle · DALLAS, TXDirectorMichaelson Capital Sff Ii, LLC · NEW YORK, NYDirectorTheodore D. Lithgow · Durham, NCExecRobert T. Mcclellan · Nashville, TNDirectorAmir W. Matityahu · Nashville, TNDirectorCarrie S. Cox · Durham, NCExec · DirectorEverett Goings · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗